Link Between Global β-Amyloid, Tau Deposition Varies by Sex
By Elana Gotkine HealthDay Reporter
MONDAY, April 14, 2025 -- Women and individuals with a paternal history of Alzheimer disease (AD) have a stronger association between global β-amyloid (Aβ) and tau deposition, according to a study published online April 9 in Neurology.
Valentin Ourry, Ph.D., from McGill University in Montreal, and colleagues examined whether sex or affected AD parent's sex influence Aβ and tau burden/accumulation in a sample of 243 participants from the Presymptomatic Evaluation of Experimental or Novel Treatments for AD cohort in Canada.
All participants were cognitively unimpaired at baseline. Longitudinal cognitive data were available for 242 participants (follow-up, 6.72 ± 2.38 years). Seventy-one participants developed mild cognitive impairment. The researchers found greater tau deposition in women (standardized β, 0.13 ± 0.3); the association between global Aβ and tau deposition was stronger for women than men (standardized β = 0.79 ± 0.1). A stronger association between global Aβ and tau deposition was seen for individuals with an affected AD father versus those with an affected AD mother (standardized β = 0.65 ± 0.1). Less Aβ-associated hippocampal atrophy was seen over time for women (standardized β = 0.24 ± 0.1).
"Women and, surprisingly, individuals with an affected AD father, seem to be more vulnerable to the spread of Aβ-related tau outside the medial temporal lobe," the authors write. "Despite this vulnerability to tau pathology, the association between Aβ and hippocampal atrophy was reduced in women, which could reflect some cause of brain resilience or the fact that Aβ is a less important driver of atrophy in women."
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1...
Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI
FRIDAY, July 11, 2025 -- For adults with chronic low back pain, gabapentin prescription is associated with an increased risk for dementia and mild cognitive impairment (MCI)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.